The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

covispharma.com

Founded Year

2011

Stage

Acq - Fin | Alive

About Covis Pharma

Covis Pharma is a specialty pharmaceutical distributor dedicated to improving the lives of people with life-threatening conditions and chronic illnesses.On February 6th, 2020, Covis Pharma was acquired by Apollo Asset Management. Terms of the transaction were not disclosed.

Covis Pharma Headquarter Location

Baarn,

Netherlands

866-488-4423

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Covis Pharma Patents

Covis Pharma has filed 9 patents.

The 3 most popular patent topics include:

  • Progestogens
  • Rare diseases
  • Androgens and anabolic steroids
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/30/2021

4/19/2022

Progestogens, Androgens and anabolic steroids, Pregnanes, Estranes, Prodrugs

Grant

Application Date

6/30/2021

Grant Date

4/19/2022

Title

Related Topics

Progestogens, Androgens and anabolic steroids, Pregnanes, Estranes, Prodrugs

Status

Grant

Latest Covis Pharma News

Covis Pharma Group Announces Executive Leadership Appointment in Canada

Jul 14, 2022

Zug, SWITZERLAND ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- Covis Pharma Group (the “Company”), a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, today announced the appointment of Christine Poulin as Senior Vice President & General Manager, Canada, effective August 8, 2022. Based in Canada, Christine will join the Company’s Executive Leadership Team and report to Chief Operating Officer Michelle Lock. “We are pleased to welcome Christine to Covis Pharma after a targeted search and are excited about the proven leadership that she will bring to her new role. With a currently marketed broad respiratory portfolio, and a new product launch soon to occur, Christine and our Canada business team are well positioned to capture sustained and meaningful growth,” said Michelle Lock, Chief Operating Officer at Covis Pharma. “I would also like to thank Jim Hall, who has played a key role to advance our Canada business over the past three years.” As a leading pharmaceutical professional with in-depth expertise across marketing, sales, product management, stakeholder relations, and communications, Christine brings over 25 years of distinguished leadership experience and will be responsible for leading the Company’s Canadian operations. “I am thrilled to join the team at Covis Pharma and continue building on the organization’s success in bringing needed solutions to patients with serious medical conditions and their healthcare providers, both in Canada and around the world,” commented Christine Poulin, incoming Senior Vice President & General Manager, Canada. Christine previously served as the Country General Manager, Canada at Teva Pharmaceuticals, where she had full P&L and leadership responsibility for a CAD $1 billion dollar business. Christine led the combined Canada based businesses of Teva Generics and Over the Counter (OTC) products as well as the Teva innovation products business, where she focused on launching new products, biologics and biosimilars. Prior to Teva, Christine worked for Endo Pharmaceuticals/Paladin Labs, Theratechnologies, Sanofi-Aventis, Pfizer, and GlaxoSmithKline, in commercial roles of increasing scope and scale. Christine has a bachelor’s degree in Commerce from McGill University and an MBA degree from Hautes Études Commerciales, Université de Montréal, both located in Canada. About Covis Pharma Covis Pharma, founded in 2011 and headquartered in Luxembourg, is a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses. Additional information is available at  www.covispharma.com . Media Contact

Covis Pharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Covis Pharma Rank

  • When was Covis Pharma founded?

    Covis Pharma was founded in 2011.

  • Where is Covis Pharma's headquarters?

    Covis Pharma's headquarters is located at Baarn.

  • What is Covis Pharma's latest funding round?

    Covis Pharma's latest funding round is Acq - Fin.

  • Who are the investors of Covis Pharma?

    Investors of Covis Pharma include Apollo Global Management and Concordia Healthcare.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.